Skip to content
healthcare.dev

TIOPRONIN

NDC 0254-3035, TIOPRONIN, tablet, delayed release, from Par Health USA, LLC.

Product NDC
0254-3035
Status
Listed
Labeler
Par Health USA, LLC
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217219
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0254-3035 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIOPRONIN300 mg/1

Pharmacologic classes

Cystine Disulfide Reduction [MoA]; N-substituted Glycines [CS]; Reducing and Complexing Thiol [EPC]

Package NDCNDC-11Package
0254-3035-090025430350990 TABLET, DELAYED RELEASE in 1 BOTTLE (0254-3035-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5396b9fd-5385-44fd-a8ba-e56a46a33bc7

Use it

Look up 0254-3035 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0254-3035 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0254-3035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.